(Q44147084)

30 November 2017

title

Quantification of hepatitis B virus genomes and infectivity in human serum samples (English)

1 reference

30 November 2017

1 reference

1 reference

2

Robert H Purcell

1 reference

30 November 2017

4

Peter A Lachenbruch

0 references

author name string

Chu Chieh Hsia

series ordinal

1

1 reference

30 November 2017

Mahmood Farshid

series ordinal

3

1 reference

30 November 2017

Mei-Ying W Yu

series ordinal

5

1 reference

30 November 2017

publication date

1 October 2006

1 reference

30 November 2017

1 reference

30 November 2017

volume

46

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

1829-1835

1 reference

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

An assay for the detection of the DNA genome of hepatitis B virus in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

New quantitative assay of hepatitis B and C viruses by competitive PCR using alternative internal sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Quantification of hepatitis B virus DNA using competitive PCR and a scintillation proximity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Real-time quantitation of hepatitis B virus (HBV) DNA in tumorous and surrounding tissue from patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Infection of a human hepatoma cell line by hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Comparison of two methods for quantification of hepatitis B viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00974.X

10.1111/J.1537-2995.2006.00974.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference